Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Erasca Reports Third Quarter 2026 Business Updates and Financial Results
GlobeNewswire, Inc.
ERAS-0015 granted FDA Fast Track Designation for metastatic pancreatic adenocarcinoma; advancing toward three potentially registration-enabling trials in pancreatic and lung cancers Updated ERAS-0015 monotherapy and nonclinical ERAS-0015/ERAS-4001...
ADARx Reports Third Quarter 2026 Financial Results and Provides Business Updates
GlobeNewswire, Inc.
– Completed initial public offering (IPO) and concurrent private placement generating aggregate gross proceeds of approximately $602.5 million; cash position expected to fund operations into 2030 – – Advanced three Phase 2 clinical trials for...
4DMT Reports Third Quarter 2026 Financial Results, Operational Highlights and Expected Upcoming Milestones
GlobeNewswire, Inc.
Completed enrollment and randomization of the 4FRONT-2 Global Phase 3 clinical trial, the second of two pivotal trials of 4D-150 in wet AMD; topline data for 4FRONT-1 and 4FRONT-2 expected in Q2 2027 and H2 2027, respectively Presented 2-year data...
NuCana Reports Third Quarter 2026 Financial Results and Provides Business Update
GlobeNewswire, Inc.
Development Programme for NUC-7738 Advances with Three Presentations Planned at ESMO Immuno-Oncology & Advanced Therapies Congress in December 2026 European Composition-of-Matter Patent Granted for NUC-7738 NUC-3373 Development Pathway Established...
Assembly Biosciences Reports Third Quarter 2026 Financial Results and Recent Updates
GlobeNewswire, Inc.
– Initiated Phase 2 clinical study of ABI-6250 in patients with chronic hepatitis delta virus infection – – Exercised 40% U.S. Profit-Share option for the HSV helicase primase inhibitor program – – Received first $75 million collaboration...
Most Consumers Plan to Purchase Private Brands This Holiday Season, New Report Finds
GlobeNewswire, Inc.
ST. LOUIS, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Advantage Solutions Inc. (NASDAQ: ADV), the leading omnichannel retail solutions agency in North America, and its private brands business, Daymon, today released the Holiday 2026 Private Brand...
New Pacific Institute Report Shows How Climate Disasters Can Drive Up Water Bills in the US
GlobeNewswire, Inc.
Oakland, California, USA, Nov. 12, 2026 (GLOBE NEWSWIRE) -- The Pacific Institute today releases Paying for Climate Disasters on the Water Bill, a report that introduces a new framework, the Water Affordability-Climate Disaster Feedback Loop, to...
Can-Fite Pivotal Phase III Psoriasis Study Under an FDA- and EMA-agreed protocol: All Patients Completed Dosing and Interim Analysis Expected Q1 2027
GlobeNewswire, Inc.
The study evaluates oral Piclidenoson and last patient in the interim-analysis cohort completes treatment Ramat Gan, Israel, Nov. 18, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a clinical-stage...
78% of Shoppers Have Walked Out Over Rush-Hour Store Problems, New Logile Report Finds
GlobeNewswire, Inc.
DALLAS, Nov. 12, 2026 (GLOBE NEWSWIRE) -- As retailers head into the stretch from Black Friday through New Year’s, when crowds push stores harder than any other time of year, shoppers are already walking away from ordinary busy-hour trips.
NUGL Reports Q3 2026 Results as KAYA Marks a Decade in Jamaica’s Regulated Cannabis Market
GlobeNewswire, Inc.
KINGSTON, Jamaica and LOS ANGELES, Nov. 12, 2026 (GLOBE NEWSWIRE) -- NUGL, Inc. (OTC: NUGL) (“NUGL” or the “Company”), operator of the KAYA cannabis and lifestyle brand in Jamaica, today reported results for the three and nine months ended...
ENSG Class Action: Ensign Group Investors Bring Securities Class Action Following Neglect Issues – Contact BFA Law by December 7 Deadline
GlobeNewswire, Inc.
NEW YORK, Nov. 18, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against The Ensign Group, Inc. (NASDAQ:ENSG) and certain of the company’s senior executives for...
Aquestive Therapeutics to Present at the Piper Sandler 38th Annual Healthcare Conference
GlobeNewswire, Inc.
WARREN, N.J., Nov. 18, 2026 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a biopharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative...
Monopar Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Updates
GlobeNewswire, Inc.
WILMETTE, Ill., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical‐stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, today...
CRISP & GREEN® CELEBRATES 10 YEARS WITH $100,000 GIVEBACK AS BRAND CLOSES IN ON 100 RESTAURANTS NATIONWIDE
EIN Presswire
CRISP & GREEN® is celebrating its 10th anniversary with Fuel It Forward, a nationwide campaign.
Taysha Gene Therapies Reports Third Quarter 2026 Financial Results and Provides Corporate Update
GlobeNewswire, Inc.
REVEAL pivotal and ASPIRE trials evaluating TSHA-102 for Rett syndrome ongoing; expect to report topline data from 6-month interim analysis and FDA feedback on BLA submission pathway in 1H 2027 TSHA-102 continues to be generally well tolerated...
Manitoba gets ready to round up and win big with its inaugural Great Twine Round-Up Contest
GlobeNewswire, Inc.
CARMEN, Manitoba, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Cleanfarms celebrates the launch of Manitoba’s first-ever Great Twine Round-Up Contest.
Report Launch: The US$842 billion opportunity for food and climate
EIN Presswire
New report sets out how governments can use “immense financial lever” of agricultural subsidy reform to tackle climate change and fix broken food systems.
Intellia Therapeutics Presents Additional Positive Clinical and Patient-Reported Data for Lonvoguran Ziclumeran (lonvo-z) at ACAAI 2026
GlobeNewswire, Inc.
Among patients previously on long-term prophylaxis (LTP) in HAELO Phase 3 trial, monthly attack rate decreased by 81% following lonvo-z dosing compared with prior LTP 100% of patients receiving 50 mg of lonvo-z across Phase 1/2 clinical trial and...
Belite Bio Reports Unaudited Third Quarter 2026 Financial Results and Provides a Corporate Update
GlobeNewswire, Inc.
New Drug Application (NDA) for tinlarebant in Stargardt disease type 1 (STGD1) granted priority review by the U.S. Food and Drug Administration (FDA) in August 2026 with Prescription Drug User Fee Act (PDUFA) target action date of February 12,...
Where Food Comes From, Inc. Reports Third Quarter Financial Results
GlobeNewswire, Inc.
Third Quarter Highlights – 2026 vs. 2025 Verification and certification revenue up 6% to $5.9M from $5.6M Product sales flat at $1.2M Total revenue up 4% to $7.3M from $7.0M Gross margin improves to 42.1% from 38.3% Operating income up 68% to...
Sign up for:
Food & Beverage Report
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.